L’information et le consentement de la femme au dépistage prénatal non invasif

Benachi, Alexandra; Vivanti, Alexandre J.

doi:10.4000/cdst.6623

cdst

2022

DOI: 10.4000/cdst.6623

|View full text |Cite

L’information et le consentement de la femme au dépistage prénatal non invasif

Alexandra Benachi¹,

Alexandre J. Vivanti²

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Women's preferences for NIPT as a first‐line test in England and France: Challenges for genetic counseling practices

Perrot,

Clarke,

Vassy

et al. 2023

Journal of Genetic Counseling

View full text Add to dashboard Cite

Non‐invasive prenatal testing (NIPT) is provided in the private and public sectors worldwide as a first‐ or second‐tier test. In England and France, NIPT is fully funded and offered as a contingent strategy with different probability cut‐offs (1:150 and 1:1000). These different approaches to define the target population for NIPT have implications for how women experience their antenatal care. The paper explores and compares the perceptions and difficulties of women in England and France who took NIPT as a second‐tier screening test. It is based on a semi‐structured qualitative interview study with 17 women in England and France conducted between September 2021 and May 2022. The interviews were cross‐analyzed using thematic analysis. Our findings show that most women express a preference for the offer of NIPT as a first‐line screening test. Some issues with the contingent model, related to the access to information and termination of pregnancy (TOP), the disparities of NIPT uptake, and risks of generating anxiety with combined first‐trimester screening (cFTS), could be addressed by a universal strategy for T21, T13, and T18. Nevertheless, this strategy could present some challenges for genetic counseling due to: women's understanding and expectations of NIPT; adequate information and counseling about the scope and limits of NIPT; concerns about the routinization of NIPT in the first‐line offer; limitations and uncertainties associated with the provision of expanded NIPT in France; the remaining importance of other screening tests; and associated costs.

show abstract

Women's preferences for NIPT as a first‐line test in England and France: Challenges for genetic counseling practices

Perrot,

Clarke,

Vassy

et al. 2023

Journal of Genetic Counseling

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

L’information et le consentement de la femme au dépistage prénatal non invasif

Cited by 1 publication

References 11 publications

Women's preferences for NIPT as a first‐line test in England and France: Challenges for genetic counseling practices

Women's preferences for NIPT as a first‐line test in England and France: Challenges for genetic counseling practices

Contact Info

Product

Resources

About